Abbott Laboratories Shares Outstanding 2006-2018 | ABT

Current and historical number of shares outstanding for Abbott Laboratories (ABT) from 2006 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Abbott Laboratories Annual Shares Outstanding
(Millions of US $)
2017 $1,749
2016 $1,483
2015 $1,506
2014 $1,527
2013 $1,574
2012 $1,592
2011 $1,567
2010 $1,556
2009 $1,555
2008 $1,561
2007 $1,560
2006 $1,537
2005 $1,564
Abbott Laboratories Quarterly Shares Outstanding
(Millions of US $)
Q2 2018 $1,769
Q1 2018 $1,765
Q4 2017 $1,749
Q3 2017 $1,754
Q2 2017 $1,749
Q1 2017 $1,735
Q4 2016 $1,483
Q3 2016 $1,476
Q2 2016 $1,480
Q1 2016 $1,484
Q4 2015 $1,506
Q3 2015 $1,505
Q2 2015 $1,504
Q1 2015 $1,516
Q4 2014 $1,527
Q3 2014 $1,520
Q2 2014 $1,517
Q1 2014 $1,548
Q4 2013 $1,574
Q3 2013 $1,567
Q2 2013 $1,577
Q1 2013 $1,586
Q4 2012 $1,592
Q3 2012 $1,594
Q2 2012 $1,589
Q1 2012 $1,590
Q4 2011 $1,577
Q3 2011 $1,568
Q2 2011 $1,566
Q1 2011 $1,559
Q4 2010 $1,556
Q3 2010 $1,554
Q2 2010 $1,552
Q1 2010 $1,561
Q4 2009 $1,555
Q3 2009 $1,552
Q2 2009 $1,551
Q1 2009 $1,556
Q4 2008 $1,561
Q3 2008 $1,564
Q2 2008 $1,553
Q1 2008 $1,561
Q4 2007 $1,560
Q3 2007 $1,558
Q2 2007 $1,561
Q1 2007 $1,558
Q4 2006 $1,537
Q3 2006 $1,542
Q2 2006 $1,532
Q1 2006 $1,538
Q4 2005 $1,564
Q3 2005 $1,564
Q2 2005 $1,569
Q1 2005 $1,570
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $111.627B $27.390B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $123.073B 19.05
Stryker (SYK) United States $62.161B 24.02
Boston Scientific (BSX) United States $46.605B 24.25
Baxter (BAX) United States $37.778B 25.71
Zimmer Biomet Holdings (ZBH) United States $24.903B 16.00
Smith & Nephew SNATS (SNN) United Kingdom $15.491B 0.00
ResMed (RMD) United States $15.453B 30.67
Bio-Rad Laboratories (BIO) United States $9.687B 62.27
Perrigo (PRGO) Ireland $9.503B 13.48
Hill-Rom Holdings (HRC) United States $6.289B 21.33
ICU Medical (ICUI) United States $6.001B 40.67
Canopy Growth (CGC) Canada $5.429B 0.00
Haemonetics (HAE) United States $5.340B 48.73
Insulet (PODD) United States $5.133B 0.00
Agios Pharmaceuticals (AGIO) United States $4.525B 0.00
Neogen (NEOG) United States $4.386B 69.89
Hutchison China MediTech (HCM) China $4.128B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.707B 0.00
NuVasive (NUVA) United States $3.433B 32.57
National Vision Holdings (EYE) United States $3.287B 72.72
Quidel (QDEL) United States $2.771B 56.77
Phibro Animal Health (PAHC) United States $2.014B 29.91
NxStage Medical (NXTM) United States $1.858B 0.00
Cardiovascular Systems (CSII) United States $1.239B 745.00
Eagle Pharmaceuticals (EGRX) United States $1.195B 35.27
VAREX IMAGING (VREX) United States $1.118B 18.26
AtriCure (ATRC) United States $1.092B 0.00
Omeros (OMER) United States $1.001B 0.00
Orthofix (OFIX) United States $1.001B 30.48
OraSure Technologies (OSUR) United States $0.995B 65.08
TG Therapeutics (TGTX) United States $0.977B 0.00
Surmodics (SRDX) United States $0.976B 117.90
Cerus (CERS) United States $0.974B 0.00
Owens & Minor (OMI) United States $0.947B 10.13
MacroGenics (MGNX) United States $0.866B 0.00
LeMaitre Vascular (LMAT) United States $0.707B 33.91
PetIQ (PETQ) United States $0.694B 23.76
Meridian Bioscience (VIVO) United States $0.632B 21.59
Insys Therapeutics (INSY) United States $0.560B 0.00
Evolus (EOLS) United States $0.530B 0.00
Lantheus Holdings (LNTH) United States $0.515B 16.01
NanoString Technologies (NSTG) United States $0.413B 0.00
Cytosorbents (CTSO) United States $0.346B 0.00
BioLife Solutions (BLFS) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.335B 21.60
Quanterix (QTRX) United States $0.315B 0.00
Surface Oncology (SURF) United States $0.275B 0.00
Rockwell Medical (RMTI) United States $0.245B 0.00
Chimerix (CMRX) United States $0.202B 0.00
Fonar (FONR) United States $0.170B 10.32
Chembio Diagnostics (CEMI) United States $0.163B 0.00
Bovie Medical (BVX) United States $0.156B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.120B 0.00
Female Health (VERU) United States $0.109B 0.00
Trinity Biotech (TRIB) Ireland $0.091B 27.13
Oramed Pharmaceuticals (ORMP) Israel $0.087B 0.00
United-Guardian (UG) United States $0.086B 18.94
Neurotrope (NTRP) United States $0.077B 0.00
InfuSystems Holdings (INFU) United States $0.076B 0.00
CAS Medical Systems (CASM) United States $0.067B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Capricor Therapeutics (CAPR) United States $0.030B 0.00
Akers Biosciences Inc (AKER) United States $0.028B 0.00
Myomo (MYO) United States $0.025B 0.00
Senestech (SNES) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00